TriSalus Life Sciences Stock (NASDAQ: TLSI) stock price, news, charts, stock research, profile.
You can purchase shares of TriSalus Life Sciences (NASDAQ:TLSI) through any online brokerage.
Other companies in TriSalus Life Sciences’s space includes: Cabaletta Bio (NASDAQ:CABA), Adverum Biotechnologies (NASDAQ:ADVM), Atossa Therapeutics (NASDAQ:ATOS), Tonix Pharmaceuticals (NASDAQ:TNXP) and Lineage Cell Therapeutics (AMEX:LCTX).
TriSalus Life Sciences has a consensus price target of $11.75.
The stock price for TriSalus Life Sciences (NASDAQ: TLSI) is $4.06 last updated December 20, 2024 at 6:43 PM EST.
There are no upcoming dividends for TriSalus Life Sciences.
TriSalus Life Sciences’s Q3 earnings are confirmed for Thursday, November 14, 2024.
There is no upcoming split for TriSalus Life Sciences.
TriSalus Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.